These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7885939)

  • 1. Ventriculoatrial conduction in patients with implantable cardioverter defibrillators: implications for tachycardia discrimination by dual chamber sensing.
    Li HG; Thakur RK; Yee R; Klein GJ
    Pacing Clin Electrophysiol; 1994 Dec; 17(12 Pt 1):2304-6. PubMed ID: 7885939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of sinus tachycardia from ventricular tachycardia with 1:1 ventriculoatrial conduction in dual chamber implantable cardioverter defibrillators: feasibility of a criterion based on the atrioventricular interval.
    LeCarpentier GL; Baga JJ; Yang H; Steinman RT; Meissner MD; Lehmann MH
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1818-31. PubMed ID: 7838794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventriculoatrial conduction capability and prevalence of 1:1 retrograde conduction during inducible sustained monomorphic ventricular tachycardia in 305 implantable cardioverter defibrillator recipients.
    Militianu A; Salacata A; Meissner MD; Grill C; Mahmud R; Palti AJ; Ben David J; Mosteller R; Lessmeier TJ; Baga JJ; Pires LA; Schuger CD; Steinman RT; Lehmann MH
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 1):2378-84. PubMed ID: 9358476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventriculoatrial conduction metrics for classification of ventricular tachycardia with 1:1 retrograde conduction in dual-chamber sensing implantable cardioverter defibrillators.
    Thompson JA; Jenkins JM
    J Electrocardiol; 1998; 31 Suppl():152-6. PubMed ID: 9988021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial sensing to augment ventricular tachycardia detection by the automatic implantable cardioverter defibrillator: a utility study.
    Schuger CD; Jackson K; Steinman RT; Lehmann MH
    Pacing Clin Electrophysiol; 1988 Oct; 11(10):1456-64. PubMed ID: 2462223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of tachycardia cycle length variability in discriminating atrial tachycardia from ventricular tachycardia.
    Jongnarangsin K; Pumprueg S; Prasertwitayakij N; Crawford TC; Mukerji S; McLemore-McGregor R; Chen-Scarabelli C; Ebinger M; Good E; Chugh A; Bogun F; Pelosi F; Oral H; Morady F
    Heart Rhythm; 2010; 7(2):225-8. PubMed ID: 20022818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: state-of-the-art review.
    Swerdlow CD
    J Cardiovasc Electrophysiol; 2001 May; 12(5):606-12. PubMed ID: 11386525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A:V = 1:1 cardiac arrhythmia detection by VA interval analysis.
    Stevenson SA; Thiagarajan B; Jenkins JM; DiCarlo LA
    J Electrocardiol; 1996; 29 Suppl():198-201. PubMed ID: 9238399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing function.
    Israel CW; Grönefeld G; Iscolo N; Stöppler C; Hohnloser SH
    Pacing Clin Electrophysiol; 2001 Feb; 24(2):183-90. PubMed ID: 11270697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequacy of qualitative implantable cardioverter defibrillator electrogram analysis to distinguish supraventricular from ventricular tachycardia due to electrogram changes during normally conducted complexes.
    Hallett N; Monahan K; Casavant D; Epstein L; Josephson M
    Pacing Clin Electrophysiol; 1997 Jun; 20(6):1723-6. PubMed ID: 9227776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachycardia detection in modern implantable cardioverter-defibrillators.
    Brüggemann T; Dahlke D; Chebbo A; Neumann I
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):171-85. PubMed ID: 27576695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention.
    Lee WC; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):231. PubMed ID: 27871248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators.
    Tuan TC; Lo MT; Lin YJ; Hsieh WH; Lin C; Huang NE; Lo LW; Chao TF; Liao JN; Hsieh YC; Wu TJ; Chen SA
    J Cardiovasc Electrophysiol; 2014 Apr; 25(4):411-417. PubMed ID: 24320556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators.
    Theuns DA; Rivero-Ayerza M; Goedhart DM; van der Perk R; Jordaens LJ
    Heart Rhythm; 2006 Nov; 3(11):1332-8. PubMed ID: 17074640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lewis Lead for Detection of Ventriculoatrial Conduction Type.
    Huemer M; Meloh H; Attanasio P; Wutzler A; Parwani AS; Matsuda H; Blaschke F; Boldt LH; Haverkamp W
    Clin Cardiol; 2016 Feb; 39(2):126-31. PubMed ID: 26812168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.